中国のスキンケアおよびトリートメント市場 2023

$850.00

製品コード: CH04746I 業界: 領域:

説明
The maintenance of skin health and prevention of skin conditions through proper skincare practices are crucial. Skincare not only shields the skin from environmental factors like UV radiation, pollution, and harsh weather conditions but also assists in managing and alleviating various skin conditions such as dryness, acne, and dermatitis. さらに, skincare plays a vital role in wound healing, radiation therapy, and minimizing the side effects of certain medications.

最新の研究によると, the skin care and treatment market in China is projected to experience significant growth. It is anticipated to increase by USD 79.0 billion during the period of 2023-2029, 複合年間成長率 (CAGR) の 9.88%. Several factors contribute to this growth, including the rising consumer awareness about skincare, increasing disposable income, and evolving lifestyles. Consumers are becoming more conscious of their skin health and are willing to invest in high-quality skincare products, which drives the demand for such products and propels the growth of the market.

This industry report provides comprehensive market estimates for the Chinese market, coupled with a detailed analysis of its types and regions. The skin care and treatment market in China can be segmented based on type into functional skincare, medical dressing, and general skincare. これらのセグメントの中では, the general skincare segment accounted for the highest revenue generation in 2022. In terms of geographic segmentation, the market is further divided into North China, 北東中国, 東中国, South Central China, Southwest China, and Northwest China.

The functional skincare market can be further classified into recombinant collagen, animal-derived collagen, hyaluronic acid, active ingredients from plants, その他. Among these subsegments, the active ingredients from plants held the largest market share in 2022. しかし, the recombinant collagen segment is expected to exhibit the highest CAGR during the forecast period. さらに, the medical dressing market has been categorized into recombinant collagen, animal-derived collagen, hyaluronic acid, その他. Among these categories, the recombinant collagen segment is projected to grow at the highest CAGR during the forecast period.

主要企業と競争環境
The skin care and treatment market in China is highly competitive, with several key players dominating the industry. These leading companies include Yunnan Botanee Bio-technology Group Co. 株式会社, L’Oréal S.A., Bloomage Biotechnology Corp. 株式会社, 企業として, Harbin Fuerjia Technology Co. 株式会社, Allmed Medical Products Co. 株式会社, Guangzhou Trauer Biotechnology Co. 株式会社, and Winner Medical Co. 株式会社.

This data-centric report emphasizes market trends, status, and outlook for each segment. With a comprehensive assessment across major geographies, this report serves as a valuable asset for existing market players, new entrants, and future investors.

このレポートを購入する理由?
Get a detailed picture of the China Skin Care and Treatment Market
Identify segments/areas to invest in over the forecast period in the China Skin Care and Treatment Market
競争環境を理解する, 市場の主要企業
Excel 形式でのシナリオ全体の分析を容易にするための市場予測.
3ヶ月間の戦略コンサルティングとリサーチサポート.
シングルユーザーライセンスに提供される印刷認証.

中国のスキンケアおよびトリートメント市場 2023

このレポートに興味がある? 今すぐ無料サンプルを入手してください!
中国のスキンケアおよびトリートメント市場 2023 - レポートの範囲
レポート属性

詳細

市場規模 (2022)

米ドル 95.4 十億

基準年

2022

予測年

2023-2029

CAGR (2023-2029)

9.88%

ページ

21

セグメント化基準

タイプ, 領域

対象地域

北中国, 北東中国, 東中国, South Central China, Southwest China, Northwest China

キープレーヤー

Yunnan Botanee Bio-technology Group Co. 株式会社, L'Oréal S.A., Bloomage Biotechnology Corp. 株式会社, 企業として, Harbin Fuerjia Technology Co. 株式会社, Allmed Medical Products Co. 株式会社, Guangzhou Trauer Biotechnology Co. 株式会社, Winner Medical Co. 株式会社.

関連レポート
このレポートをカスタマイズしたい?
このレポートには、お客様の特定のニーズに合わせて調整できる柔軟性があります。. 当社のアナリストと業界専門家のチームは、お客様と直接協力して、お客様の要件を包括的に理解します。.

無料サンプルをダウンロード - 中国のスキンケアおよびトリートメント市場 2023

フォームにご記入ください。折り返しご連絡させていただきます.